Compound Radar

Clover Health Investments, Corp. (CLOV) Stock Analysis

United States · Healthcare / Healthcare Plans

Price $4.31
Market cap $2.37B
Next earnings Nov 4, 2026
Entry status Watch 2.9%

Last updated Nov 2, 2026

Health Check

Last analyzed Nov 2, 2026

51
51/100 Speculative
  • Financial Health 60
  • Profitability 70
  • Business Quality 60
  • Balance Sheet 65
  • Cash Flow 35

Why this rating?

Health 51/100 — Speculative

Strongest Profitability 70/100
Softest Cash Flow 35/100
Watch 2.9%

Worth tracking, but timing is mixed — not a clear setup yet.

Company overview

Clover Health Investments, Corp. (CLOV) is a Healthcare Plans company in the Healthcare sector. Compound Radar rates Clover Health Investments, Corp. 51/100 (Speculative) due to strong revenue growth and fair valuation.

Investment profile

  • Quality Speculative
  • Growth Strong
  • Balance Sheet Unknown
  • Valuation Fair

Financial highlights

Valuation

  • Forward P/E 29.73
  • EV/Revenue 0.86

Profitability

  • Revenue Growth 55.6%
  • Gross Margin 18.5%
  • Operating Margin 3.8%
  • Net Margin -0.7%
  • ROE -5.1%

Financial strength

  • Cash $243.10M
  • Debt $0.00
  • Net Cash $243.10M
  • Free Cash Flow $-68.98M
  • Current Ratio 1.5

Similar companies

Peers in Healthcare Plans, ranked by Financial Health.

View all in Healthcare Plans →

FAQ

How Compound Radar scores and tracks Clover Health Investments, Corp. (CLOV).

View Methodology & FAQ →